Results 131 to 140 of about 14,040 (225)
Lipid Lowering and Incidence of Cataract, a Role for Fibrates
, 2019 Cataract is a pathological eye condition with loss of lens transparency. Age-related cataract is the most common type in adults, and opacity is believed to result from oxidative stress.
Casula M., Catapano A. L., Pirillo A.
core +1 more source
, 2021 At present, statins are included in the first line of dyslipidemia therapy. Fibrates also take a certain place in the treatment of dyslipidemia. Given the above, it is advisable to study the pharmacoeconomic characteristics of fibrates presented on the
Bezdetko, N. V. +6 more
core
CellsCardiovascular diseases remain the leading cause of death in the world, and that is why finding an effective and multi-functional treatment alternative to combat these diseases has become more important.
María Esther Rubio-Ruíz +4 more
doaj +1 more source
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor [PDF]
In view of the evidence linking plasma high density lipoprotein (HDL)-cholesterol levels to a protective effect against coronary artery disease and the widespread use of fibrates in the treatment of hyperlipidemia, the goal of this study was to analyze ...
Vu-Dac, N. +6 more
core +1 more source
Effects of Fibrates in Kidney Disease A Systematic Review and Meta-Analysis
, 2012 ObjectivesThe purpose of this systematic review and meta-analysis was to determine the efficacy and safety of fibrate therapy in the chronic kidney disease (CKD) population.BackgroundFibrate therapy produces modest cardiovascular benefits in people at ...
Meg J. Jardine +19 more
core +1 more source
Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
, 2016 Fibrates are drugs used for the treatment of hypertriglyceridemia and for the prevention of atherosclerosis. Three drugs in the fibrate class, ciprofibrate, fenofibrate and bezafibrate, were chosen for this study because their raw materials are readily ...
Marcelo Antonio de Oliveira (12847535) +2 more
core +1 more source
The hypolipidemic fibrates and antidiabetic thiazolidinediones display potent triglyceride-lowering activities. Studies on the molecular action mechanisms of these compounds indicate that thiazolidinediones and fibrates exert their action by activating ...
Staels, B. +3 more
core +1 more source
Российский кардиологический журнал, 2006 The authors studied effects of short-term (8 weeks) combined lipid-lowering and antihypertensive therapy effects on hemostatic parameters in metabolic syndrome (MS) patients.
L. A. Ratnikova +4 more
doaj